All the VC-backed IPOs in the US so far this year

Unity Biotechnology. Magenta Therapeutics. ARMO BioSciences. Verrica Pharmaceuticals. Notice a pattern? They're all VC-backed healthcare companies, and they've all gone public since the beginning of this year.

Of the VC-backed companies in the US that have conducted IPOs so far in 2018, nearly two-thirds are part of the healthcare industry. And the spike in healthcare companies hitting the public markets represents a larger trend: VC-backed IPOs in general are booming.

So far, just about halfway through 2018, the total deal value for VC-backed IPOs in the US stands at $6.9 billion, per PitchBook data. If the pace keeps up, this year will be second to only 2012 in terms of IPO deal value—and 2012 is a bit of an outlier, as it includes Facebook's record-breaking public offering. The number of public debuts in 2018 is high, too: This year is set to see around 85 VC-backed IPOs in the US, a number that's only been exceeded in 2007, 2013 and 2014.

The healthcare sector, which encompasses devices & supplies, drug discovery and biotechnology, is by far the most active industry for IPOs this year. Of the 41 venture-backed companies based in the US that have gone public over the past six months, 27 fall in the healthcare sector, per PitchBook data. Next comes IT: Eleven companies in that industry have conducted IPOs since the beginning of 2018, including Dropbox, DocuSign and Zscaler.

Here's a look at all the US-based VC-backed companies that have gone public so far in 2018, ranked in terms of valuation at the time of their debut:

 

Company name	Month of IPO	Years from founding to IPO	Industry sector	Money raised in IPO	Value at IPO
Dropbox	March	10.8	IT	$756.0M	$8.2B
DocuSign	April	15.1	IT	$629.3M	$4.4B
Pluralsight	May	14.4	B2C	$310.5M	$2.0B
Zscaler	March	11.2	IT	$192.0M	$1.9B
Avalara	June	14.5	IT	$180.0M	$1.6B
Smartsheet	April	13.3	IT	$174.5M	$1.5B
Zuora	April	11.6	IT	$154.0M	$1.4B
Ecovacs	May	20.4	B2C	$126.1M	$1.3B
Carbon Black	May	16.3	IT	$152.0M	$1.3B
Vobile	January	12.5	IT	$206.4M	$1.1B
Unity Biotechnology	May	9.3	Healthcare	$85.0M	$712.4M
Huami	February	5.1	Healthcare	$110.0M	$653.8M
Arcus Biosciences	March	3.2	Healthcare	$120.0M	$638.3M
Eidos Therapeutics	June	5.5	Healthcare	$106.3M	$608.9M
Homology Medicines	March	3.2	Healthcare	$144.0M	$577.3M
Solid Biosciences	January	5.1	Healthcare	$125.0M	$546.4M
nLIGHT	April	18.3	B2B	$96.0M	$537.9M
Aptinyx	June	2.8	Healthcare	$102.4M	$520.6M
Magenta Therapeutics	June	1.6	Healthcare	$100.0M	$515.6M
Evelo Biosciences	May	4.4	Healthcare	$85.0M	$509.9M
ARMO BioSciences	January	5.2	Healthcare	$128.0M	$497.7M
Forty Seven	June	3.5	Healthcare	$113.0M	$478.2M
Neon Therapeutics	June	4.7	Healthcare	$100.0M	$451.2M
EverQuote	June	9.9	IT	$84.4M	$446.5M
Avrobio	June	3.5	Healthcare	$99.7M	$439.8M
ElectroCore	June	13.5	Healthcare	$78.0	$426.4M
Surface Oncology	April	4.3	Healthcare	$108.0M	$414.0M
resTORbio	January	1.1	Healthcare	$85.0M	$407.9M
Verrica Pharmaceuticals	June	5.5	Healthcare	$75.0M	$374.2M
Menlo Therapeutics	January	7.1	Healthcare	$119.0M	$372.8M
UNUM Therapeutics	March	4.2	Healthcare	$69.2M	$355.4M
Scholar Rock	May	6.4	Healthcare	$75.0M	$342.2M
Inspire Medical Systems	May	11.3	Healthcare	$108.0M	$323.9M
Xeris Pharmaceuticals	June	13.5	Healthcare	$85.5M	$296.0M
Kezar Life Sciences	June	3.5	Healthcare	$75.0M	$274.8M
Cardlytics	February	10.1	B2B	$70.2M	$253.8M
Eyenovia	January	4.1	Healthcare	$27.3M	$99.4M
Genprex	March	9.2	Healthcare	$6.4M	$65.2M
One Stop Systems	February	20.1	IT	$19.0M	$61.7M
Tricida	June	4.9	Healthcare	$222.3M	–
Translate Bio	June	8.5	Healthcare	$121.6M	–